NVO logo

Novo Nordisk A/S (NVO) Working capital

annual working capital:

-$7.86B-$3.42B(-76.84%)
December 31, 2024

Summary

  • As of today (August 23, 2025), NVO annual working capital is -$7.86 billion, with the most recent change of -$3.42 billion (-76.84%) on December 31, 2024.
  • During the last 3 years, NVO annual working capital has fallen by -$5.74 billion (-269.44%).
  • NVO annual working capital is now -311.85% below its all-time high of $3.71 billion, reached on December 31, 2009.

Performance

NVO Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

quarterly working capital:

-$7.05B+$1.89B(+21.10%)
June 1, 2025

Summary

  • As of today (August 23, 2025), NVO quarterly working capital is -$7.05 billion, with the most recent change of +$1.89 billion (+21.10%) on June 1, 2025.
  • Over the past year, NVO quarterly working capital has dropped by -$5.56 billion (-371.37%).
  • NVO quarterly working capital is now -288.20% below its all-time high of $3.75 billion, reached on June 30, 2011.

Performance

NVO quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

NVO Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-76.8%-371.4%
3 y3 years-269.4%-651.3%
5 y5 years-1607.3%-843.3%

NVO Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-329.9%at low-651.3%+21.1%
5 y5-year-1607.3%at low-843.3%+21.1%
alltimeall time-311.9%at low-288.2%+21.1%

NVO Working capital History

DateAnnualQuarterly
Jun 2025
-
-$7.05B(-21.1%)
Mar 2025
-
-$8.94B(+13.6%)
Dec 2024
-$7.86B(+76.8%)
-$7.86B(+298.0%)
Sep 2024
-
-$1.98B(+32.1%)
Jun 2024
-
-$1.50B(-79.0%)
Mar 2024
-
-$7.12B(+60.1%)
Dec 2023
-$4.45B(+143.1%)
-$4.45B(+3.2%)
Sep 2023
-
-$4.31B(+54.3%)
Jun 2023
-
-$2.79B(+6.3%)
Mar 2023
-
-$2.63B(+43.7%)
Dec 2022
-$1.83B(-14.1%)
-$1.83B(+28.9%)
Sep 2022
-
-$1.42B(+51.3%)
Jun 2022
-
-$938.52M(-30.8%)
Mar 2022
-
-$1.36B(-36.3%)
Dec 2021
-$2.13B(+190.1%)
-$2.13B(-573.4%)
Sep 2021
-
$449.65M(-35.2%)
Jun 2021
-
$693.40M(-139.9%)
Mar 2021
-
-$1.74B(+136.8%)
Dec 2020
-$733.79M(-240.7%)
-$733.79M(-271.3%)
Sep 2020
-
$428.34M(-54.8%)
Jun 2020
-
$948.62M(>+9900.0%)
Mar 2020
-
$882.30K(-99.8%)
Dec 2019
$521.71M(-30.5%)
$521.71M(+1041.5%)
Sep 2019
-
$45.70M(-85.9%)
Jun 2019
-
$324.23M(-206.4%)
Mar 2019
-
-$304.72M(-140.6%)
Dec 2018
$751.08M(-64.2%)
$751.08M(+2.4%)
Sep 2018
-
$733.60M(-43.8%)
Jun 2018
-
$1.30B(+37.5%)
Mar 2018
-
$948.21M(-54.9%)
Dec 2017
$2.10B(+20.1%)
$2.10B(+10.5%)
Sep 2017
-
$1.90B(-18.2%)
Jun 2017
-
$2.32B(+139.6%)
Mar 2017
-
$970.12M(-44.5%)
Dec 2016
$1.75B(-15.8%)
$1.75B(+16.1%)
Sep 2016
-
$1.51B(-9.1%)
Jun 2016
-
$1.66B(+104.2%)
Mar 2016
-
$811.72M(-60.9%)
Dec 2015
$2.08B(+1.4%)
$2.08B(+7.1%)
Sep 2015
-
$1.94B(+48.5%)
Jun 2015
-
$1.31B(+517.2%)
Mar 2015
-
$211.62M(-89.7%)
Dec 2014
$2.05B(-37.8%)
$2.05B(+8.3%)
Sep 2014
-
$1.89B(-1.7%)
Jun 2014
-
$1.92B(+28.4%)
Mar 2014
-
$1.50B(-54.6%)
Dec 2013
$3.29B(+0.6%)
$3.29B(+19.0%)
Sep 2013
-
$2.77B(+43.0%)
Jun 2013
-
$1.94B(+10.4%)
Mar 2013
-
$1.75B(-46.5%)
Dec 2012
$3.27B(-0.4%)
$3.27B(+29.3%)
Sep 2012
-
$2.53B(+22.9%)
Jun 2012
-
$2.06B(-19.9%)
Mar 2012
-
$2.57B(-21.8%)
Dec 2011
$3.29B
$3.29B(-1.2%)
DateAnnualQuarterly
Sep 2011
-
$3.32B(-11.3%)
Jun 2011
-
$3.75B(+14.4%)
Mar 2011
-
$3.28B(-3.3%)
Dec 2010
$3.39B(-8.7%)
$3.39B(+8.8%)
Sep 2010
-
$3.11B(+22.2%)
Jun 2010
-
$2.55B(-11.6%)
Mar 2010
-
$2.88B(-22.3%)
Dec 2009
$3.71B(+23.4%)
$3.71B(+4.6%)
Sep 2009
-
$3.55B(+9.2%)
Jun 2009
-
$3.25B(+25.5%)
Mar 2009
-
$2.59B(-13.9%)
Dec 2008
$3.01B(+12.3%)
$3.01B(+7.7%)
Sep 2008
-
$2.79B(-13.0%)
Jun 2008
-
$3.21B(+14.9%)
Mar 2008
-
$2.79B(+4.3%)
Dec 2007
$2.68B(+41.8%)
$2.68B(+12.4%)
Sep 2007
-
$2.38B(+6.2%)
Jun 2007
-
$2.25B(+22.3%)
Mar 2007
-
$1.84B(-2.8%)
Dec 2006
$1.89B(+33.0%)
$1.89B(+23.3%)
Sep 2006
-
$1.53B(-11.3%)
Jun 2006
-
$1.73B(+27.6%)
Mar 2006
-
$1.35B(-4.6%)
Dec 2005
$1.42B(-25.8%)
$1.42B(-0.6%)
Sep 2005
-
$1.43B(+12.7%)
Jun 2005
-
$1.27B(-18.0%)
Mar 2005
-
$1.55B(-19.1%)
Dec 2004
$1.91B(+19.7%)
$1.91B(+23.7%)
Sep 2004
-
$1.55B(+6.5%)
Jun 2004
-
$1.45B(+6.0%)
Mar 2004
-
$1.37B(-14.3%)
Dec 2003
$1.60B(+45.0%)
$1.60B(+45.0%)
Dec 2002
$1.10B(+17.1%)
$1.10B(+17.1%)
Dec 2001
$941.03M(+22.3%)
$941.03M(+22.3%)
Dec 2000
$769.32M(-39.0%)
$769.32M(-17.1%)
Dec 1999
$1.26B(+5.9%)
$927.97M(-21.8%)
Dec 1998
$1.19B(+8.6%)
$1.19B(+7.5%)
Dec 1997
$1.10B(+6.6%)
$1.10B(+7.9%)
Dec 1996
$1.03B(-0.0%)
$1.02B(-0.3%)
Dec 1995
$1.03B(+4.2%)
$1.03B(-27.6%)
Dec 1994
$987.10M(+21.9%)
$1.42B(+74.2%)
Dec 1993
$809.60M(-3.3%)
$813.89M(-28.8%)
Dec 1992
$836.81M(+6.9%)
$1.14B(+46.0%)
Dec 1991
$783.14M(+83.3%)
$783.22M(+83.4%)
Dec 1990
$427.30M(+2.5%)
$427.06M(+2.9%)
Dec 1989
$416.70M(+32.8%)
$415.11M(+32.0%)
Dec 1988
$313.81M(-7.2%)
$314.45M(-7.5%)
Dec 1987
$338.34M(+15.5%)
$339.96M(+16.1%)
Dec 1986
$292.84M(-2.3%)
$292.90M(-2.2%)
Dec 1985
$299.66M(+38.1%)
$299.51M(+37.9%)
Dec 1984
$216.98M(-4.1%)
$217.20M
Dec 1983
$226.27M(+72.9%)
-
Dec 1982
$130.89M(-16.3%)
-
Dec 1981
$156.47M(+85.6%)
-
Dec 1980
$84.32M
-

FAQ

  • What is Novo Nordisk A/S annual working capital?
  • What is the all time high annual working capital for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual working capital year-on-year change?
  • What is Novo Nordisk A/S quarterly working capital?
  • What is the all time high quarterly working capital for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly working capital year-on-year change?

What is Novo Nordisk A/S annual working capital?

The current annual working capital of NVO is -$7.86B

What is the all time high annual working capital for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual working capital is $3.71B

What is Novo Nordisk A/S annual working capital year-on-year change?

Over the past year, NVO annual working capital has changed by -$3.42B (-76.84%)

What is Novo Nordisk A/S quarterly working capital?

The current quarterly working capital of NVO is -$7.05B

What is the all time high quarterly working capital for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly working capital is $3.75B

What is Novo Nordisk A/S quarterly working capital year-on-year change?

Over the past year, NVO quarterly working capital has changed by -$5.56B (-371.37%)
On this page